RedixFi
Market closedNIFTY25,030.35+2.0%Volatile3 event(s)
Market feed live

NIVABUPA · Niva Bupa Health Insurance Company Ltd · Insurance (Accident & Health)

NIVABUPA · Niva Bupa Health Insurance Company Ltd · Insurance (Accident & Health)

₹76.08-0.9%

As of 06 Nov close

52-week range

52wk low ₹67.552wk high ₹91.4

16.8% below 52-week high

52-week range: as of 06 Nov 2026 close.

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 16 Oct 2026

Operating margin above its own average

Revenue (latest Q)

₹2,426 Cr

Revenue YoY

PAT YoY

+92.9%

Operating margin

Revenue, last 8 quarters

P/E (TTM)

P/B

3.7

P/S (TTM)

1.9

Sector P/E

11.5

Dividend yield

0.0%

CompanyP/EP/BNet marginROED/EDiv. yield
NIVABUPA (this stock)42.73.7+4.7%+9.4%00.0%
Max Financial Services650.99.9+0.2%+1.6%35.19Not available from data source
Max IndiaNot available from data source2-62.0%-32.5%0.240.0%

Promoter

falling 1q

FII

rising 2q

MF

9.35% (-0.45pp)

falling 1q

Insider trades

No insider trades in the last 12 months.

Bulk/block deals

No bulk/block deals in the last 12 months.

News timeline

No related news.

Concalls & investor presentations

AI-generated
Concall transcriptPositive03 Aug 2026
View source filing →

Key takeaway: Niva Bupa Health Insurance Company Limited held its Q1 FY27 earnings conference call on July 30, 2026, where management provided updates on industry initiatives and company performance. Management reported a retail health growth of 35.5% and an overall growth of 23.0% on a like-to-like basis. The company transitioned to Ind AS accounting standards and noted a significant improvement in its combined insurance service ratio to 100.2%. Management highlighted a challenging pricing environment for group business, which remained flat. The company achieved a profit after tax of INR137.8 crores and improved its claims settlement rate to 95.6%. Additionally, Niva Bupa was recognized as one of the top 50 Great Places to Work in India. The management discussed ongoing strategies to enhance growth, including expanding its advisor network and leveraging AI capabilities. The call concluded with management expressing gratitude to participants.

Management highlighted several growth achievements and improvements in operational metrics.

Sourced from an exchange-filed transcript, dated 03 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive30 Jul 2026
View source filing →

Key takeaway: Niva Bupa Health Insurance Company Limited reported its Q1 FY2027 performance, highlighting a 31.7% year-on-year growth in Gross Written Premium (GWP) to ₹2,150 crore, with a Profit After Tax (PAT) of ₹137.8 crore, nearly doubling from ₹71.4 crore in Q1 FY2026. The company noted a Combined Insurance Service Ratio (CISR) of 100.2%, an improvement from 103.2% in the previous year. The retail health market share increased to 11.1% from 10.0%. Management emphasized the transition to Indian Accounting Standards (Ind AS) as a significant milestone for financial transparency. Niva Bupa was recognized as the 41st among India’s Top 100 Great Places to Work in 2026, up from 67th the previous year. The Weighted Episodal Net Promoter Score (NPS) improved to 62, reflecting enhanced customer service. The presentation also outlined the company's strategy focused on technology-driven growth and diversified distribution channels.

Management highlighted strong growth metrics and improvements in customer satisfaction.

Sourced from an exchange-filed presentation, dated 30 Jul 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive13 May 2026
View source filing →

Key takeaway: Niva Bupa Health Insurance Company Limited held its Q4 FY '26 earnings conference call on May 8, 2026, where management provided insights into the company's performance and industry developments. Management reported a strong overall growth rate of 27.4% for gross written premium (GWP) at INR 9,433 crores, with retail growth exceeding 40% in the second half of the fiscal year. Profit after tax increased to INR 366 crores, up from INR 203 crores the previous year. The company emphasized the positive impact of the GST reform and ongoing industry initiatives aimed at improving healthcare transparency and affordability. Management highlighted a focus on talent management, achieving a 94% claims settlement rate, and the implementation of advanced technologies across operations. The combined ratio improved to 101.4%, driven by a reduction in the expense ratio. Management expressed confidence in maintaining growth through a diversified distribution strategy and expanding into new customer segments.

Management highlighted strong growth and positive industry developments.

Sourced from an exchange-filed transcript, dated 13 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Investor presentationPositive08 May 2026
View source filing →

Key takeaway: Niva Bupa Health Insurance Company Limited reported its audited financial results for the fiscal year ending March 31, 2026, during the earnings conference call. Management highlighted a 27.4% year-on-year growth in Gross Written Premium (GWP), reaching ₹9,432.9 crore, and a Profit After Tax (PAT) of ₹366 crore, up from ₹203 crore in FY2025. The Combined Insurance Service Ratio (CISR) improved to 101.4% from 103.0% in the previous year. The health insurance segment experienced a significant growth rate of 16.7%, supported by favorable regulatory changes. Niva Bupa's retail health market share increased to 10.1% from 9.4% in FY2025. The company also emphasized its commitment to transparency with the adoption of Indian Accounting Standards (Ind AS) starting April 2026. Additionally, Niva Bupa was recognized among India’s Top 25 Best Workplaces in BFSI, reflecting its focus on employee culture and service excellence.

Management emphasized strong growth and positive recognition in the industry.

Sourced from an exchange-filed presentation, dated 08 May 2026. Summary is RedixFi-generated and distinct from investment advice.

Concall transcriptPositive03 Feb 2026
View source filing →

Key takeaway: Niva Bupa Health Insurance Company Limited held its Q3 FY'26 earnings conference call on January 29, 2026, where management discussed several key developments and performance metrics. Management highlighted a commitment to spending Rs. 120-140 crores annually on insurance awareness campaigns and emphasized initiatives to create a more transparent insurance ecosystem. The company reported a 26% growth rate for the first nine months, with a retail growth rate of 33%. Profit after tax increased by 74% year-on-year to Rs. 208 crores. The combined ratio improved slightly, and the retail loss ratio remained stable at 66.9%. Management noted the successful launch of the Reassure 3.0 product and ongoing advancements in AI capabilities. The call concluded with management expressing confidence in meeting regulatory requirements and maintaining a strong solvency ratio of 2.49.

Management emphasized strong growth and positive developments in the business.

Sourced from an exchange-filed transcript, dated 03 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.

AI Summary of Annual Report

AI-generated
FY2024-25266 pages

Niva Bupa Health Insurance Company Limited reported a 90.8% increase in Profit after Tax (IFRS) to ₹203 crore in FY2024-25, with a 32.1% growth in Gross Written Premium to ₹7,407 crore. The company's Solvency Ratio improved to 3.03x, and it maintained a 92.4% claim settlement ratio. The Indian health insurance segment grew by 9.1% to ₹1.27 lakh crore in FY25, with Niva Bupa capturing a significant share. However, the growth rate of Net Worth decreased to 49.22% YoY, down from 146.6% in FY24, and the Combined Ratio was 96.1% (Without 1/n), indicating near breakeven underwriting performance. The company faced no significant regulatory orders or insolvency proceedings, and its financial statements were audited without material misstatements.

  • Profit after Tax (IFRS) increased by 90.8% to ₹203 crore in FY2024-25.
  • Gross Written Premium grew by 32.1% to ₹7,407 crore.
  • Solvency Ratio improved to 3.03x.
  • Net Worth growth rate decreased to 49.22% YoY.
  • No significant regulatory orders or insolvency proceedings were reported.

Key takeaway: Niva Bupa Health Insurance Company Limited delivered strong financial performance with significant profit growth and improved solvency, but its net worth growth rate declined, and underwriting performance remained near breakeven.

The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.

Filed with NSE · 31 Jul 2025View source filing →

Governance disclosures

AI-generated

Needs attention

Regulatory Action (1 item)

Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.

Regulatory Action

1 occurrence

Earlier (1-3 years ago)

Annual Report31 Jul 2025 (FY2024-25)· 4 passages
View source filing →

The Stock Exchange imposed a fine on Niva Bupa Health Insurance Company Limited for non-compliance with Regulation 52(1) of the Listing Regulations, as the Board meeting for approval of financial results for the quarter ended 30th September 2024 was held on 25th November 2024.

Routine disclosures

Contingent Liability

1 occurrence

Earlier (1-3 years ago)

Annual Report31 Jul 2025 (FY2024-25)· 4 passages
View source filing →

The company has disputed income tax demands totaling ₹ 9,879 Lakhs and ₹ 1,158 Lakhs with pending appeals, and a GST refund rejection of ₹ 2,213 Lakhs, along with a GST demand of ₹ 3,318 Lakhs, all of which are contingent liabilities.

Open full Signal Dashboard →